Overview
Nosemosis, caused by the microsporidian parasites Vairimorpha (Nosema) apis and V. (Nosema) ceranae, is a significant fungal disease affecting Western honey bees (Apis mellifera). This condition is critical due to its role in colony collapse and the broader implications for pollination services, biodiversity, and agricultural economies. Given the alarming decline in bee populations over the past two decades, nosemosis stands out as a key factor contributing to these losses. Accurate diagnosis and management are essential for beekeepers and veterinarians to mitigate the impact on honey bee colonies, ensuring their health and productivity in day-to-day practice 15.Pathophysiology
Nosemosis initiates when honey bees ingest spores of Vairimorpha species, typically through contaminated water, food, or hive structures. These spores germinate in the ventriculus (midgut) of the bee, where they penetrate epithelial cells via a polar tubule and release sporoplasm. The sporoplasm undergoes rapid division within host cells, forming new spores that infect neighboring cells or are expelled via feces, perpetuating the cycle 5. Histologically, the ventriculus exhibits significant changes, including distension of epithelial cells due to intracellular edema and abundant spore accumulation. As infection progresses, the gut wall becomes uneven, with signs of cell degeneration, necrosis, and reduced peritrophic membrane integrity, ultimately leading to impaired nutrient digestion and starvation of the bee 1215.Epidemiology
Nosemosis is widespread globally, affecting honey bee colonies irrespective of geographic location, though regional variations in prevalence exist. The incidence of nosemosis has notably increased alongside the decline in bee populations over the past two decades, suggesting a correlation with environmental stressors such as climate change and pesticide exposure 15. Specific incidence and prevalence figures are not consistently reported across studies, but trends indicate higher susceptibility in colonies under stress or in areas with intensive agricultural practices 13.Clinical Presentation
Clinical signs of nosemosis can vary widely depending on the causative agent. Infections by V. apis often manifest with more overt symptoms, including milky-white midguts, swollen abdomens, and dysentery, whereas V. ceranae infections tend to be subtler, primarily leading to immunosuppression, energy stress, and poor colony development 115. Subclinical infections are common, complicating early detection. Red-flag features include sudden colony declines, reduced brood rearing, and increased adult bee mortality, which warrant immediate diagnostic evaluation 5.Diagnosis
Diagnosing nosemosis traditionally relies on manual spore counting from the ventriculus of affected bees using a hemocytometer, a method developed in 1970 114. However, this method's reliability is questioned due to its inconsistent correlation with clinical signs 1625. More recent advancements include the use of monoclonal antibodies (mAbs) for immunofluorescence assays (IFAT), which offer high sensitivity and specificity comparable to PCR, making them valuable alternatives in laboratories without access to advanced molecular techniques 2. Histological examination can also provide insights into the severity of infection by assessing the extent of ventricular epithelial cell damage and spore accumulation 1.Management
Effective management of nosemosis involves a combination of preventive measures and targeted interventions.Preventive Measures
Treatment Approaches
Complications
Untreated nosemosis can lead to severe colony collapse, reduced honey production, and broader ecological impacts due to decreased pollination services. Key triggers for complications include prolonged high spore loads and concurrent stressors like pesticide exposure or environmental changes 5.Prognosis & Follow-up
The prognosis for nosemosis-infected colonies varies based on the severity of infection and the timeliness of intervention. Early detection and treatment generally yield better outcomes. Regular follow-up involves monitoring spore counts, colony health indicators, and brood patterns every 4-6 weeks post-treatment to ensure sustained recovery 5.Special Populations
Key Recommendations
References
1 Racine E, Bégin-Pépin M, Benoit-Biancamano MO. Histopathology of nosemosis in honey bees: correlation with manual counting and comparison of staining methods. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2026. link 2 Izquierdo F, Fernández Vadillo C, Fenoy S, Hurtado-Marcos C, Magnet A, Higes M et al.. Production and characterization of monoclonal antibodies for specific detection of Nosema ceranae and Nosema apis in beehive samples. International journal for parasitology 2025. link 3 Zheng S, Huang Y, Chen J, Wei J, Pan G, Li C et al.. A specific molecular label for identifying mature Nosema bombycis spores. Journal of invertebrate pathology 2020. link 4 Li Z, Pan G, Li T, Huang W, Chen J, Geng L et al.. SWP5, a spore wall protein, interacts with polar tube proteins in the parasitic microsporidian Nosema bombycis. Eukaryotic cell 2012. link 5 Cox JC, Pye D. Serodiagnosis of nosematosis by immunofluorescence using cell-culture-grown organisms. Laboratory animals 1975. link